Exopharm Limited (ASX:EX1)
Share Price and News
Exopharm Limited is an ASX listed regenerative medicine company. It offers age-related treatment through its proprietary technology under which the company develops and commercializes exosomes as the therapeutic agents. The company aims to become leading human clinical therapeutics using exosomes as regenerative medicine products. The company got listed on Australian Securities Exchange on 18 December 2018.